Epidermal growth factor receptor (EGFR) activation by growth factors (GFs) relies on 17 dimerization and allosteric activation of its intrinsic kinase activity, resulting in trans-18 phosphorylation of tyrosines on its C-terminal tail. While structural and biochemical 19 studies identified this EGF-induced allosteric activation, imaging collective EGFR 20 activation in cells and molecular dynamics simulations pointed at additional catalytic 21 EGFR activation mechanisms. To gain more insight in EGFR activation mechanisms 22
in living cells, we developed a Förster Resonance Energy Transfer (FRET) based 23 conformational EGFR indicator (CONEGI) using genetic code expansion that reports 24 on conformational transitions in the EGFR activation loop. Comparing 25 conformational transitions, self-association and auto-phosphorylation of CONEGI and 26 its Y845F mutant revealed that Y 845 phosphorylation induces a catalytically active 27 conformation in EGFR monomers. This conformational transition depends on EGFR 28 kinase activity and auto-phosphorylation on its C-terminal tail, generating a looped 29 causality that leads to autocatalytic amplification of EGFR phosphorylation at low 30 EGF dose. 31
Dimerization of EGFR by GFs activates its intrinsic kinase activity, which trans-33 phosphorylates tyrosine residues on the C-terminal receptor tail 1, 2 . SH2-or PTB-34 containing signal transducing proteins are then recruited to these phosphorylated 35 tyrosines, propagating the signal in the cytoplasm 3, 4 . Structural data of EGFR indicate 36 that in absence of ligand a closed tethered extracellular domain (ECD) and association 37 of the intracellular tyrosine kinase domain (TKD) with the negatively charged plasma 38 membrane (PM) by two polybasic stretches favor steric auto-inhibition of EGFR's 39 intrinsic kinase activity [5] [6] [7] . Ligand binding to EGFR is coupled to conformational 40 changes in the extra-and intracellular domains and overcomes intrinsic auto-41 inhibition resulting in allosteric activation via asymmetric dimer formation of the 42 TKD 2,5 . For this, the αC-helix located in the N lobe of the TKD moves from its 'out'-43 configuration to an ordered 'in'-configuration, while the activation loop frees the 44 catalytic cleft and undergoes conformational rearrangements of ~20 Å 8-10 . Despite the 45 steric auto-inhibitory features, autonomous EGFR phosphorylation was observed in 46 several cancer types including breast and lung cancer that either exhibit high EGFR 47
surface concentrations through EGFR overexpression or bear oncogenic mutations 48 favoring an active conformation 9,11-13 . Spontaneous auto-phosphorylation of 49 unliganded EGFR can occur due to thermal fluctuations that overcome intrinsic steric 50 auto-inhibition [14] [15] [16] . These auto-phosphorylation events can trigger an autocatalytic 51 amplification mechanism when they induce an active conformation that further 52 catalyzes EGFR auto-phosphorylation 15 . Molecular dynamics simulations suggested 53 that Y 845 phosphorylation in the EGFR activation loop suppresses intrinsic disorder in 54 the αC-helix thereby stabilizing an active receptor conformation as well as increasing 55 EGFR dimerization 9 . We therefore investigated whether EGFR can adopt an active 56 conformation upon Y 845 phosphorylation and how this impacts on collective EGFR 57 phosphorylation dynamics in living cells. A clear avenue to obtain a better insight in 58 collective EGFR activation is to monitor conformational dynamics of the TKD. For 59 this, we engineered a FRET-based conformational EGFR indicator (CONEGI) using 60 genetic code expansion. In contrast to existing kinase activity sensors based on 61 substrate phosphorylation 17 , CONEGI was designed to report on conformational 62 transitions in a functional domain of the EGFR TKD by the change in distance and 63 orientation of a fluorophore conjugated to an unnatural amino acid (UAA) relative to 64 the fluorescent protein mCitrine inserted into a conformationally invariant region. 65
Based on structural data, we identified the end of the TKD as an insertion site for 66 mCitrine that is conformationally invariant and does not affect EGFR function. UAA 67 incorporation and subsequent site specific labeling at position 851 created a FRET-68 based sensor that reports on conformational transitions of the EGFR activation loop. 69
This construct retained EGFR dimerizing and catalytic functionality. Monitoring 70 conformational transitions together with dimerization and auto-phosphorylation and 71 comparing these readouts to a CONEGI Y845F mutant revealed that an active 72 conformation in monomeric receptors is induced by Y 845 phosphorylation. We then 73
show that Y 845 phosphorylation depends on auto-phosphorylation of the C-terminal 74 tail, which creates an autocatalytic loop that amplifies EGFR phosphorylation at low, Supplementary Table 1 ). This showed that the 851-118 site yielded the highest (21%) FRET efficiency. We conjugated Atto590 to the desired 119 site in the TKD in a two-step process to generate conformational EGFR indicators 120 Expression of EGFR(BCNKXXX)-QG-mCitrine variants in HEK293T cells was 129 dependent on BCNK (Figure 1d ). Whereas EGFR(BCNK851)-QG-mCitrine was 130 expressed at a comparable level to EGFR-QG-mCitrine, all other variants exhibited 131 reduced expression (Figure 1d) . EGFR(BCNKXXX)-QG-mCitrine labeling with tet-132
Atto590 was selective, as judged by both, fluorescence imaging of cell lysates 133 following SDS PAGE, and co-localization of mCitrine and Atto590 fluorescence at 134 the PM and intracellular compartments as visualized in living cells by confocal 135 microscopy (Figure 1d,e ). All EGFR(BCNKXXX)-QG-mCitrine variants exhibited a 136 similar localization as compared to an EGFR variant C-terminally tagged with 137 mTurquoise (EGFR-mTurquoise) (Supplementary Figure 1d) . In addition to their 138 comparable PM distribution (Supplementary Figure 1d,e ), all CONEGI constructs 139 exhibited a pericentriolar localization similar to EGFR-mTurquoise. This 140 pericentriolar compartment was identified to be the Rab11-positive recycling 141 endosome (Supplementary Figure 1f) , which was previously shown to maintain 142 EGFR at the PM by continuous recycling 15, 25 . 143
144
To experimentally determine whether EGFR(BCNKXXX)-QG-mCitrine labeling 145
with Atto-590 results in FRET, we imaged the fluorescence lifetime (τ) of mCitrine 146 after addition of tet-Atto590 to living cells by FLIM. For all CONEGI's we obtained a 147 significant decrease in τ of mCitrine from 3.02 ± 0.004 ns to 2.67 ± 0.039 ns over a 148 20 min time course, corresponding to an average E FRET between 10-14% as calculated 149
, -
, where Atto590 conjugation to BCNK incorporated into the 851 150 site yielded the highest FRET efficiency (14.3 ± 0.8%) (Figure 1f,g) . These 151 experimental E FRET values were in broad agreement with the theoretical predictions, exhibiting equal or lower values possibly due to the relative orientation between the 153 dyes, which affects the parameter κ 2 in R 0 (Supplementary Table 1, Figure 1g ). 154 CONEGI-712/713 exhibited the fastest labeling kinetics, with a reaction time clearly 155 below 5 min, which likely reflects the high accessibility of this site for fluorophore 156 attachment (Figure 1g) . The drop in τ of mCitrine associated with tet-Atto590 157 conjugation was reversed for all CONEGI's upon Atto590 photobleaching 158 Figure 1g,h) . Furthermore, tet-Atto590 addition to cells co-159 expressing EGFR-QG-mCitrine and the BCNK incorporation system in presence of 160 BCNK did not lead to an alteration in τ of mCitrine (Figure 1g,h) . This demonstrated 161 that the obtained changes in τ in the CONEGI's result from specific FRET between 162 mCitrine and Atto590 conjugated to site-specifically incorporated BCNK and not 163 from tet-Atto590 non-specifically bound to EGFR or the PM, or from labeling of 164 BCNK that might be incorporated at genomic amber codons. Washout of unbound tet-165
(Supplementary
Atto590 after labeling of cells did not abolish the decrease in τ of mCitrine for the 166 CONEGI's, confirming that the conjugation of tet-Atto590 to BCNK is stable 167 (Supplementary Figure 1i) . The negative correlation of τ with the Atto590 168 fluorescence intensity and the saturation of the binding curves at high Atto590 169
concentrations for all CONEGI's further confirmed specificity of tet-Atto590-170 conjugation to BCNK in EGFR (Figure 1h) . 171
172

FRET changes report on conformational transitions of the activation loop in 173
CONEGI-851 174
To investigate whether the CONEGI's report on conformational changes in the TKD 175 that occur upon activation, we measured τ of mCitrine at the PM by FLIM following 176 stimulation with EGF to cells. We observed a significant decrease in τ of CONEGI-737, -843 and -851 and a significant increase in τ of CONEGI-712/713 upon EGF 178 stimulation, whereas τ of CONEGI-713 and -730 did not significantly change ( Figure  179 2a; Supplementary Figure 2a ). To account for the variability in the completeness of 180 the Atto590 labeling reaction that affects the initial FRET efficiency in a particular 181 CONEGI construct, the difference in τ (Δτ) relative to the τ before stimulation in each 182 experiment was plotted (Figure 2b) . This Δτ-time plot that follows the general trends 183 of the τ-time plot ( Supplementary Figure 2a ) clearly reflects the conformational 184 transitions of the CONEGI constructs. Neither τ of EGFR-QG-mCitrine in presence 185 of tet-Atto590 nor τ of EGFR(BCNK851)-QG-mCitrine in absence of tet-Atto590 did 186 change upon EGF addition, precluding photophysical effects that change τ of 187 mCitrine upon EGF stimulation (Figure 2b; Supplementary Figure 2b) . Western blot analysis. Consistent with PTB-mCherry recruitment, CONEGI-843 and -203 851 exhibited a similar EGF-induced fold-change in Y 1068 phosphorylation as 204 compared to EGFR-QG-mCitrine, but the relative phosphorylation level of CONEGI-205 843 was drastically reduced (Figure 2e,f; Supplementary Figure 2c ). The other 206
CONEGIs showed increased autonomous phosphorylation (CONEGI-712/713 and -207 713) or responded only marginally to EGF (CONEGI-712/713, -713, -730 and -737), 208 indicating that their activation mechanism was impaired (Figure 2e HEK293T cells expressing EGFR(BCNK851)-QG-mCitrine showed that EGF-211 mediated phosphorylation at the PM was comparable to that of EGFR-QG-mCitrine 212 (Figure 2g; Supplementary Figure 2d ), which shows that EGFR(BCNK851)-QG-213 mCitrine at the PM is fully functional. Tet-Atto590-labeling did not affect 214 autonomous or ligand-dependent EGFR phosphorylation of EGFR(BCNK851)-QG-215 mCitrine ( Supplementary Figure 2e) . We therefore conclude that CONEGI-851 216
(from now on denoted as CONEGI) most closely follows the native activation 217 mechanism of EGFR. 218
219
To investigate whether the change in FRET upon EGFR activation detected in 220 CONEGI is of intra-or intermolecular origin, we measured τ of EGFR-QG-mCitrine 221 (donor only) upon co-expression with an EGFR(BCNK851) variant that was labeled 222 with Atto590 (acceptor only). τ of EGFR-QG-mCitrine in the presence of Atto590-223 labeled EGFR(BCNK851) (2.983 ± 0.008) was close to that of EGFR-QG-mCitrine 224 FRET efficiency in CONEGI originates from the rearrangement of the activation loop 228 rather than from mCitrine reorientation upon dimerization we locked the TKD into an 229 inactive conformation using the ATP analogue EGFR inhibitor Lapatinib 28 . This 230 abolished EGF-induced CONEGI phosphorylation (Supplementary Figure 2g) but 231 did not prevent EGF-induced dimerization as measured by homo-FRET between 232 mCitrine using fluorescence anisotropy 29 (Figure 2j; Supplementary Figure 2h ). 233
Importantly, this EGF-induced dimerization of CONEGI with a Lapatinib locked 234 TKD conformation did not result in a decrease in τ as observed for CONEGI in 235 absence of inhibitor (Figure 2k ). This shows that CONEGI exclusively reports 236 conformational transitions of the activation loop, but not reorientation of mCitrine 237 upon dimerization. 238 239 Y 845 phosphorylation induces a catalytically competent conformation of 240
CONEGI monomers 241
Phosphorylation of Y 845 was previously described to affect both the conformation of 242 the EGFR TKD, and to enhance its dimerization 9 . We therefore explored if Y 845 243 phosphorylation in the activation loop is linked to an EGFR conformational state that 244 is catalytically active without dimerization. For this, we compared the dimerization 245 and conformational transition of CONEGI upon its ligand-independent 246 phosphorylation to that of a CONEGI-Y845F mutant. Ligand-independent 247 phosphorylation of EGFR is known to occur upon phosphatase inhibition by 248 (Figure 3a; Supplementary Figure 3a,b) . This led to a 256 concurrent increase in phosphorylation of Y 1068 and Y 845 (Figure 3b immunofluorescence. We could clearly observe an expression level dependent 280 increase in auto-phosphorylation that was absent in its Y845F mutant (Figure 3g Figure 3i ). This increase in auto-phosphorylation was not due to an 282 increase in dimers at higher expression as apparent from the fluorescence anisotropy 283 as function of CONEGI expression (Supplementary Figure 3a) . In an analogous 284 experiment, we related CONEGI expression by its fluorescence intensity to its 285 conformational state by fluorescence lifetime in many individual cells. Here, we could 286 clearly observe a CONEGI expression level dependent conformational transition that 287 was absent in the CONEGI-Y845F mutant (Figure 3h,i) . Together, these data show 288 that CONEGI but not its Y845F mutant is able to activate other CONEGI molecules 289 via Y 845 phosphorylation, resulting in catalytic amplification. 290
291
EGFR dimers can induce autocatalytic activation of EGFR monomers 292
We next investigated whether ligand induced EGFR dimers can activate receptor 293 monomers. At saturating EGF dose (100 ng/ml) all receptors are occupied with ligand 294 and are activated by the canonical dimerization mechanism. However, catalytic 295 amplification can take place at sub-saturating EGF dose (20 ng/ml) because only a 296 fraction of receptors will be occupied by ligand (20-30%; estimated by the ratio of 297 EGF-Alexa647/mCitrine fluorescence at 20 ng/ml over 100 ng/ml EGF-Alexa647 per 298 cell) (Supplementary Figure 4a) . We therefore compared CONEGI and CONEGI-299 Y845F phosphorylation and conformational dynamics in cells that were stimulated 300 with saturating or sub-saturating EGF dose. Upon stimulation with saturating EGF 301 dose, CONEGI and CONEGI-Y845F exhibited similar rapid Y 1068 phosphorylation 302 reaching comparable levels (Figure 4a; Supplementary Figure 4b ). CONEGI and 303 CONEGI-Y845F also exhibited similar activation loop dynamics as apparent from the 304 comparable change in τ over time (Figure 4b; Supplementary Figure 4d ). This is 305 consistent with the activation loop being rearranged to an open conformation in both 306 CONEGI and its Y845F mutant by the canonical allosteric dimerization mechanism. 307 A similar EGF-induced decrease in anisotropy for CONEGI and CONEGI-Y845F 308 confirmed that Y845F mutation does not affect its dimerization (Supplementary 309 which after rapid initial activation remained stable at ~49±7% of that of CONEGI at 316 saturating EGF (Figure 4c; Supplementary Figure 4b) . Strikingly, the change in τ 317 of CONEGI-Y845F upon sub-saturating EGF stimulation was significantly slower 318 and of lesser magnitude as compared to that of CONEGI, which was comparable to 319 that at saturating EGF (Figure 4d; Supplementary Figure 4e ). This shows that EGF-320 activated CONEGI dimers induce an active conformation in unliganded CONEGI 321 monomers by Y 845 phosphorylation (Figure 4e; Supplementary Figure 4f ). The 322 question remained if Y 845 is directly phosphorylated by the intrinsic kinase activity of 323 EGFR or whether this happens indirectly by recruitment or activation of another 324 tyrosine kinase that is dependent on C-terminal tyrosine auto-phosphorylation of 325 EGFR 34 . To address this, we investigated Y 845 phosphorylation and conformational 326 dynamics of a C-terminal tail truncated CONEGI mutant (CONEGI-ΔD969). This 327 mutant retained its ability to dimerize (Supplementary Figure 4g) , but was severely 328 impaired in Y 845 phosphorylation (Figure 4f, Supplementary Figure 4h ). At 329 saturating EGF dose, CONEGI-ΔD969 followed closely the conformational dynamics 330 of CONEGI (Figure 4g; Supplementary Figure 4i ), consistent with activation by the 331 allosteric dimerization mechanism. However, at sub-saturating EGF dose the change 332 in τ of CONEGI-ΔD969 was significantly slower and of lesser magnitude as 333 compared to that of CONEGI (Figure 4h; Supplementary Figure 4i with the full conformational transition of its activation loop, whereas this 392 amplification was absent in CONEGI-Y845F (Figure 4c,d) . This showed that EGFR 393 dimers can activate the tyrosine kinase activity of EGFR monomers by 394 phosphorylation on Y 845 . The diminished Y 845 phosphorylation and impaired 395 conformational transition in C-terminal tail truncated CONEGI-ΔD969 monomers, 396
further showed that these depend on auto-phosphorylation of the C-terminal tail 397 (Figure 4f,h and PTB domain with fluorescent proteins were generated through restriction-ligation 449 of EGFR and PTB domain cDNA into the appropriate vector. To generate EGFR-QG-450 mCitrine mCitrine flanked with a linker sequence (LAAAYSSILSSNLSSDS-451 mCitrine-SDSSLNSSLISSYAAAL) was inserted between Q958 and G959 of EGFR. 452
Site-directed mutagenesis PCR using PfuUltra High-Fidelity DNA polymerase 453 (Agilent Technologies, Santa Clara, CA) replaced coding sequences in EGFR-QG-454 mCitrine with an amber codon (TAG) to generate BCNK incorporation sites and was 455 also used to generate the CONEGI-Y845F mutant. NotI/NheI EGFR(TAG)-QG-456 mCitrine PCR fragments were inserted in a (U6-PylT*) 4 /EF1α plasmid previously 457 described in 23 . The BCNK incorporation system consists of two plasmids, (U6-458
PylT*) 4 /EF1α-PylRS to express the tRNA-synthetase and peRF1(E55D) for 459 expression of a modified eukaryotic release factor 1 (eRF1). peRF1(E55D) was 460 Human EGF (Peprotech, Hamburg, Germany) was shock frozen at a concentration of 469 100 µg/ml in PBS + 0.1% BSA and stored at -80°C. Pervanadate was freshly prepared 470 by adding sodium orthovanadate (S6508, Sigma Aldrich, St. Louis, MO) to H 2 0 2 471 (30%) according to 30 . BCNK was described earlier in 24 . Site-specific C-terminal 472 labeling of hEGF with Alexa647-maleimide (Life Technologies, Darmstadt, 473
Germany) was carried out as described previously in 50 . Tet-Atto590 was synthesized 474 by conjugating Atto590-NHS ester (79636, Sigma Aldrich, St. Louis, MO) to tet-NH 2 475 in the presence of N,N-Diisopropylethylamine (DIPEA). The product was purified 476 using HPLC and the identity of the compound confirmed by mass spectroscopy. 477
Lapatinib (231277-92-2, Cayman Chemical, Ann Arbor, MI) was solubilized in 478
Ethanol to a stock concentration of 10 mM and stored at 4°C. GmbH, Berlin, Germany) and fluorescence of mCitrine was collected using a narrow-570 band emission filter (HQ 537/26, Chroma, Olching, Germany). FLIM data were 571 analysed using the global analysis code described in 51 to obtain images of the mean 572 fluorescence lifetime τ. Pixels with a total number of counts less than 50 photons 573 were excluded from analysis. Masks for single cells or for the PM of single cells were 574 generated and the mean fluorescence τ was measured in ImageJ 575 (http://imagej.nih.gov/ij/). 576 577
Widefield anisotropy 578
Anisotropy microscopy was performed on an Olympus IX81 inverted microscope 579 (Olympus, Hamburg, Germany) equipped with a 20x/0.7 NA air objective using an 580
Orca CCD camera (Hamamatsu Photonics, Hamamatsu City, Japan) and an 581 incubation chamber (EMBL, Heidelberg, Germany). mCitrine and Atto590 were 582 excited using a MT20 illumination system. A linear dichroic polarizer (Meadowlark 583 optics, Frederick, CO) was implemented in the illumination path of the microscope, 584
and two identical polarizers were placed in an external filter wheel at orientations 585 parallel and perpendicular to the polarization of the excitation light. For each field of 586 view two images were taken, one with the emission polarizer oriented parallel to the 587 excitation polarizer ( ∥ ) and one with the emission polarizer oriented perpendicular to 588 the excitation polarizer ( 2 ). The fluorescence anisotropy (r i ) in each pixel i was 589 calculated according to: 590 4 = 4 ∥ − 2 4 ∥ + 2 2
591
To determine the G-factor (G i ) parallel and perpendicular images of the fluorophore 592 fluorescein were taken in solution. Fluorescein's anisotropy is close to zero and 593 therefore allows calculating G i by building the ratio of the perpendicular over the 594 parallel intensities. The CellR software supplied by the microscope manufacturer 595 (Olympus, Hamburg, Germany) controlled data acquisition. Live cells were imaged in 596 vitamin-free media at 37°C and 5% CO 2 and stimulated with either 100 ng/ml EGF or 597 0.33 mM pervanadate. 598
Statistical analysis 600
All results are expressed as mean ± S.E.M or in Tukey box plots. Statistical analysis 601 was performed with GraphPad Prism, version 6.0e for Mac (GraphPad Software, La 602 Jolla, CA, USA). Statistical significance was estimated either by unpaired two-tailed t 603 tests or by two-way analysis of variance (ANOVA). 604 605
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This project was partially funded by the following grants: EMBO Short-Term 612 Figure 2d) . (h) τ of EGFR-QG-mCitrine in absence (QG; n=6 cells) or presence of tetrazine-Atto590 (QG+Atto590; n=9), EGFR-QG-mCitrine co-expressed with Atto590-labeled EGFR(BCNK851) (QG+A-851+Atto590; n=36) and CONEGI (n=32) (Supplementary Figure 2f) . (Supplementary Figure 3c,d) . Figure 4b) . Figure 4d) . (c) Relative Y 1068 phosphorylation anti-EGFR and anti-GAPDH (Figure 4a,c (Figure 4b,d ).
Supplementary information for A conformational sensor based on genetic code expansion reveals an autocatalytic component in EGFR activation
(f) Representative Western blot on HEK293T lysates expressing CONEGI upon stimulation with 20 or 100 ng/ml EGF. Blots were probed with anti-pY 845 , anti-EGFR and anti-GAPDH (Figure 4e) .
(g) mCitrine fluorescence anisotropy of CONEGI-ΔD969 versus its binned mean fluorescence intensity
(F of CONEGI) per pixel upon stimulation with 100 ng/ml EGF (N=3 experiments). (h) Representative
Western blot on HEK293T lysates expressing CONEGI or CONEGI-ΔD969 upon stimulation with 100 ng/ml EGF. Blots were probed with anti-pY 845 , anti-GFP (EGFR) and anti-GAPDH (Figure 4f) .
(i) Change in Δτ of CONEGI-ΔD969 at the PM in individual HEK293T cells upon stimulation with 20 or 100 ng/ml EGF (Figure 4g,h efficiencies the orientation factor κ 2 and the refractive index were assumed to be 2/3 and 1.4.
